Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Gynecol Oncol. 2019 Feb 15;153(1):20–25. doi: 10.1016/j.ygyno.2019.01.023

Table 2:

ART regimens in AMC-081

ART regimen N (%)
NNRTI-based regimens 38
 Efavirenz-based regimen 30 (79)
 Nevirapine-based regimen 8 (21)
Protease inhibitor-based regimen 2
 Atazanavir 1(2)
 Lopinavir/ritonavir 1(2)